PETS Stock: Price, Forecast, Financials & AI Analysis

High

Open

VWAP

Vol

Mkt Cap

Low

Amount

EV/EBITDA(TTM)

Total Shares

EV/OCF(TTM)

P/S(TTM)

Market Estimates

Earnings Estimates

Revenue

YoY Chg

EPS

YoYChg

FY2026Q3

FY2026Q4

FY2027Q1

60.76M

+2%

-0.060

+100%

54.04M

+2%

-0.130

-76.79%

0.000

-100%

Estimates Revision

The market is revising Downward the revenue expectations for PetMed Express, Inc. (PETS) for FY2026, with the revenue forecasts being adjusted by -7.93% over the past three months. During the same period, the stock price has changed by 31.89%.

Revenue Estimates for FY2026

Revise Downward

-7.93%

In Past 3 Month

EPS Estimates for FY2026

Revise Upward

+83.33%

In Past 3 Month

Stock Price

Go Up

+31.89%

In Past 3 Month

Valuation Metrics

The current forward P/E ratio for Petmed Express Inc (PETS.O) is -31.43, compared to its 5-year average forward P/E of -9.33. For a more detailed relative valuation and DCF analysis to assess Petmed Express Inc 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

N/A

5Y Average PE

-9.33

Current PE

-31.43

Overvalued PE

98.40

Undervalued PE

-117.06

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

N/A

5Y Average EV/EBITDA

10.38

Current EV/EBITDA

0.00

Overvalued EV/EBITDA

15.91

Undervalued EV/EBITDA

4.86

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

5Y Average PS

1.06

Current PS

0.35

Overvalued PS

1.78

Undervalued PS

0.33

Financials

Annual

Quarterly

N/A

Total Revenue

N/A

Operating Profit

N/A

Net Income after Tax

N/A

EPS - Diluted

N/A

Free Cash Flow

N/A

Gross Profit Margin - %

N/A

FCF Margin - %

N/A

Net Margin - %

N/A

ROIC

Trading Trends

Insider

Insiders areBuying! The selling amount has increased 174.01% over the last month.

Sold

Bought

Hedge Fund

Hedge Funds are Neutral. There are no significant trading trends over the last quarter.

Sold

Bought

Congress Trading

Congress are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Insider

Insiders areBuying! The selling amount has increased 174.01% over the last month.

Sold

Bought

PETS News & Events

Events Timeline

No data

News

7.0

01-08PRnewswire

PetMed Express Faces Investigation Over Delayed Earnings, Stock Plummets 32.41%

7.0

01-01PRnewswire

PetMed Express Faces Investigation Over Delayed Earnings, Stock Plummets 32.41%

7.0

2025-12-30Globenewswire

PetMed Express Faces Investigation Over Delayed Earnings, Stock Plummets 32.41%

People Also Watch

Frequently Asked Questions

What is Petmed Express Inc (PETS) stock price today?

The current price of PETS is 3.35 USD — it has increased 0.9 % in the last trading day.

What is Petmed Express Inc (PETS)'s business?

PetMed Express, Inc., doing business as PetMeds, is a direct-to-consumer pet pharmacy. The Company is an online provider of prescription and non-prescription medications, food, supplements, and supplies and has veterinary and pet insurance service partnerships for dogs, cats, and horses. It markets and sells directly to consumers through their Websites, toll-free numbers, and employer benefit partnerships. Its product line contains over 15,000 SKUs of pet medications, health products, foods, and supplies. The Company offers various pet supplies, including beds, crates, stairs and other pet supplies. Its products include Prescription Medications (Rx), Non-Prescription Medications (OTC) and supplies, Pet Foods, Private Label and Holistic Wellness Services. Rx includes heartworm and flea and ticks preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes.

What is the price predicton of PETS Stock?

Wall Street analysts forecast PETS stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for PETS is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Petmed Express Inc (PETS)'s revenue for the last quarter?

Petmed Express Inc revenue for the last quarter amounts to 44.36M USD, decreased -23.57 % YoY.

What is Petmed Express Inc (PETS)'s earnings per share (EPS) for the last quarter?

Petmed Express Inc. EPS for the last quarter amounts to -0.41 USD, decreased -472.73 % YoY.

What changes have occurred in the market's expectations for Petmed Express Inc (PETS)'s fundamentals?

How many employees does Petmed Express Inc (PETS). have?

Petmed Express Inc (PETS) has 173 emplpoyees as of January 09 2026.

What is Petmed Express Inc (PETS) market cap?

Today PETS has the market capitalization of 70.95M USD.